Thomas Daniel Shipp, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography, Prenatal | 46 | 2023 | 1695 | 3.570 |
Why?
|
| Uterine Rupture | 14 | 2021 | 72 | 1.860 |
Why?
|
| Trial of Labor | 14 | 2021 | 80 | 1.690 |
Why?
|
| Placenta Accreta | 4 | 2023 | 225 | 1.180 |
Why?
|
| Vaginal Birth after Cesarean | 9 | 2004 | 62 | 0.960 |
Why?
|
| Fetal Diseases | 10 | 2017 | 903 | 0.900 |
Why?
|
| Uterine Hemorrhage | 7 | 2020 | 255 | 0.890 |
Why?
|
| Cesarean Section | 14 | 2023 | 1365 | 0.870 |
Why?
|
| Placenta Previa | 1 | 2023 | 117 | 0.830 |
Why?
|
| Umbilical Cord | 2 | 2018 | 180 | 0.720 |
Why?
|
| Pregnancy | 72 | 2023 | 29142 | 0.610 |
Why?
|
| Imaging, Three-Dimensional | 11 | 2018 | 4044 | 0.580 |
Why?
|
| Pregnancy Trimester, Second | 12 | 2014 | 732 | 0.510 |
Why?
|
| Uterus | 5 | 2023 | 710 | 0.480 |
Why?
|
| Down Syndrome | 8 | 2014 | 880 | 0.450 |
Why?
|
| Placenta | 5 | 2023 | 1697 | 0.430 |
Why?
|
| Adrenal Glands | 1 | 2015 | 547 | 0.430 |
Why?
|
| Nuchal Translucency Measurement | 4 | 2014 | 56 | 0.420 |
Why?
|
| Intrauterine Devices | 2 | 2010 | 122 | 0.410 |
Why?
|
| Pregnancy Trimester, Third | 8 | 2020 | 571 | 0.390 |
Why?
|
| Intrauterine Device Migration | 1 | 2010 | 6 | 0.390 |
Why?
|
| Cervix Uteri | 4 | 2020 | 590 | 0.370 |
Why?
|
| Pregnancy Trimester, First | 4 | 2018 | 853 | 0.360 |
Why?
|
| Fetus | 6 | 2014 | 1880 | 0.350 |
Why?
|
| Fetal Growth Retardation | 3 | 2019 | 570 | 0.330 |
Why?
|
| Ultrasonography | 14 | 2020 | 5982 | 0.310 |
Why?
|
| Endometrium | 4 | 2011 | 424 | 0.310 |
Why?
|
| Hysterotomy | 3 | 2021 | 22 | 0.310 |
Why?
|
| Fetal Heart | 3 | 2000 | 276 | 0.310 |
Why?
|
| Aneuploidy | 7 | 2014 | 530 | 0.300 |
Why?
|
| Premature Birth | 2 | 2020 | 1721 | 0.300 |
Why?
|
| Radiology | 8 | 2020 | 2099 | 0.300 |
Why?
|
| Diagnostic Imaging | 8 | 2020 | 3508 | 0.300 |
Why?
|
| Ilium | 2 | 1998 | 154 | 0.290 |
Why?
|
| Pelvic Pain | 3 | 2016 | 274 | 0.280 |
Why?
|
| Adnexal Diseases | 2 | 2019 | 102 | 0.260 |
Why?
|
| Societies, Medical | 11 | 2021 | 3741 | 0.260 |
Why?
|
| Pregnancy, High-Risk | 4 | 2016 | 120 | 0.260 |
Why?
|
| Sex Preselection | 1 | 2004 | 18 | 0.260 |
Why?
|
| Pregnancy Outcome | 11 | 2018 | 2796 | 0.260 |
Why?
|
| Female | 96 | 2023 | 380197 | 0.240 |
Why?
|
| Fetal Death | 4 | 2016 | 447 | 0.240 |
Why?
|
| Echocardiography | 2 | 2016 | 5103 | 0.240 |
Why?
|
| Gestational Age | 11 | 2021 | 3493 | 0.230 |
Why?
|
| Climacteric | 1 | 2003 | 57 | 0.230 |
Why?
|
| Maternal Age | 5 | 2002 | 802 | 0.230 |
Why?
|
| Puerperal Infection | 1 | 2003 | 46 | 0.220 |
Why?
|
| Pregnancy Complications | 6 | 2018 | 2862 | 0.220 |
Why?
|
| Ultrasonography, Doppler, Color | 2 | 2013 | 233 | 0.220 |
Why?
|
| Ovarian Neoplasms | 5 | 2019 | 4837 | 0.220 |
Why?
|
| Head | 2 | 2000 | 880 | 0.220 |
Why?
|
| Frontal Bone | 1 | 2002 | 105 | 0.210 |
Why?
|
| Fathers | 1 | 2004 | 358 | 0.210 |
Why?
|
| Image Enhancement | 3 | 2010 | 2921 | 0.200 |
Why?
|
| Premenopause | 3 | 2011 | 1033 | 0.200 |
Why?
|
| Prenatal Care | 2 | 2012 | 1092 | 0.200 |
Why?
|
| Chromosome Disorders | 2 | 2002 | 515 | 0.200 |
Why?
|
| Obstetrics | 4 | 2021 | 658 | 0.190 |
Why?
|
| Birth Intervals | 1 | 2001 | 51 | 0.190 |
Why?
|
| Endometrial Neoplasms | 2 | 2014 | 1353 | 0.190 |
Why?
|
| Oligohydramnios | 2 | 2001 | 35 | 0.190 |
Why?
|
| Trisomy | 1 | 2002 | 266 | 0.190 |
Why?
|
| Nose | 2 | 2014 | 509 | 0.190 |
Why?
|
| Orofaciodigital Syndromes | 1 | 2000 | 23 | 0.190 |
Why?
|
| Evidence-Based Medicine | 9 | 2020 | 3611 | 0.190 |
Why?
|
| Kidney Diseases | 1 | 2011 | 2147 | 0.180 |
Why?
|
| Registries | 1 | 2016 | 8090 | 0.180 |
Why?
|
| Surgical Wound Dehiscence | 2 | 2011 | 215 | 0.180 |
Why?
|
| Abnormalities, Multiple | 4 | 2013 | 1416 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 6 | 2015 | 7281 | 0.180 |
Why?
|
| Myometrium | 3 | 2010 | 181 | 0.180 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 1701 | 0.180 |
Why?
|
| Genital Diseases, Female | 2 | 2015 | 197 | 0.180 |
Why?
|
| Nasal Bone | 2 | 2013 | 58 | 0.170 |
Why?
|
| Humans | 99 | 2023 | 744220 | 0.170 |
Why?
|
| Karyotyping | 7 | 2000 | 1243 | 0.160 |
Why?
|
| Parity | 2 | 2010 | 929 | 0.160 |
Why?
|
| Ovary | 1 | 2003 | 981 | 0.160 |
Why?
|
| Amniocentesis | 1 | 1998 | 116 | 0.160 |
Why?
|
| Foreign-Body Migration | 2 | 2010 | 221 | 0.150 |
Why?
|
| Chromosome Aberrations | 2 | 2002 | 1814 | 0.150 |
Why?
|
| Suture Techniques | 1 | 2003 | 798 | 0.150 |
Why?
|
| alpha-Fetoproteins | 2 | 2002 | 222 | 0.150 |
Why?
|
| Medical Oncology | 3 | 2014 | 2265 | 0.150 |
Why?
|
| Obstetric Labor Complications | 1 | 1999 | 238 | 0.150 |
Why?
|
| Clubfoot | 1 | 1998 | 63 | 0.150 |
Why?
|
| Cleft Lip | 1 | 2002 | 478 | 0.150 |
Why?
|
| Cleft Palate | 1 | 2002 | 560 | 0.140 |
Why?
|
| Organ Size | 3 | 2018 | 2252 | 0.140 |
Why?
|
| Amniotic Band Syndrome | 1 | 1996 | 22 | 0.140 |
Why?
|
| Mothers | 2 | 2004 | 2165 | 0.140 |
Why?
|
| Sacrococcygeal Region | 1 | 1996 | 52 | 0.140 |
Why?
|
| Retrospective Studies | 25 | 2021 | 77426 | 0.140 |
Why?
|
| Teratoma | 2 | 1996 | 387 | 0.140 |
Why?
|
| Kidney | 1 | 2011 | 7183 | 0.130 |
Why?
|
| Postmenopause | 1 | 2005 | 2461 | 0.130 |
Why?
|
| Adult | 40 | 2021 | 214035 | 0.130 |
Why?
|
| Scrotum | 1 | 1995 | 114 | 0.130 |
Why?
|
| Pelvis | 2 | 2015 | 729 | 0.130 |
Why?
|
| Fallopian Tube Diseases | 1 | 2015 | 62 | 0.130 |
Why?
|
| Femur | 1 | 2001 | 1297 | 0.120 |
Why?
|
| Abdominal Neoplasms | 1 | 1996 | 291 | 0.120 |
Why?
|
| Logistic Models | 10 | 2008 | 13409 | 0.120 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 1996 | 254 | 0.120 |
Why?
|
| Uterine Artery Embolization | 1 | 2014 | 62 | 0.110 |
Why?
|
| Risk Factors | 15 | 2023 | 72280 | 0.110 |
Why?
|
| Hernia, Inguinal | 1 | 1995 | 210 | 0.110 |
Why?
|
| Infant, Newborn | 14 | 2023 | 25618 | 0.110 |
Why?
|
| Urology | 2 | 2014 | 399 | 0.110 |
Why?
|
| Varicose Veins | 1 | 2014 | 154 | 0.110 |
Why?
|
| Chi-Square Distribution | 3 | 2011 | 3509 | 0.100 |
Why?
|
| United States | 20 | 2021 | 69867 | 0.100 |
Why?
|
| Endometriosis | 2 | 2015 | 839 | 0.100 |
Why?
|
| Hydronephrosis | 1 | 2012 | 269 | 0.100 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2015 | 370 | 0.100 |
Why?
|
| Amniotic Fluid | 2 | 2007 | 370 | 0.090 |
Why?
|
| Obstetric Labor, Premature | 1 | 2011 | 279 | 0.090 |
Why?
|
| Sensitivity and Specificity | 8 | 2021 | 14726 | 0.090 |
Why?
|
| Diagnosis, Differential | 9 | 2019 | 12961 | 0.090 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2014 | 501 | 0.090 |
Why?
|
| Ultrasonography, Doppler | 2 | 2015 | 458 | 0.090 |
Why?
|
| Restraint, Physical | 1 | 2010 | 193 | 0.080 |
Why?
|
| Infertility, Female | 1 | 2015 | 787 | 0.080 |
Why?
|
| Pre-Eclampsia | 1 | 1997 | 1200 | 0.080 |
Why?
|
| Uterine Diseases | 1 | 2008 | 135 | 0.070 |
Why?
|
| Odds Ratio | 6 | 2008 | 9849 | 0.070 |
Why?
|
| Prenatal Diagnosis | 2 | 2023 | 1236 | 0.070 |
Why?
|
| Cerebral Ventricles | 1 | 2007 | 544 | 0.060 |
Why?
|
| Crown-Rump Length | 2 | 2014 | 32 | 0.060 |
Why?
|
| Aging | 1 | 2003 | 8661 | 0.060 |
Why?
|
| Prospective Studies | 9 | 2015 | 53280 | 0.060 |
Why?
|
| Contrast Media | 4 | 2019 | 5300 | 0.050 |
Why?
|
| Delivery, Obstetric | 2 | 2000 | 906 | 0.050 |
Why?
|
| Neoplasms, Fibroepithelial | 1 | 2001 | 8 | 0.050 |
Why?
|
| Family Planning Services | 1 | 2004 | 263 | 0.050 |
Why?
|
| Labor, Induced | 2 | 2001 | 146 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2002 | 199 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2002 | 245 | 0.050 |
Why?
|
| Maternal Welfare | 1 | 2002 | 115 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 1995 | 2732 | 0.050 |
Why?
|
| Religion | 1 | 2004 | 356 | 0.050 |
Why?
|
| Boston | 3 | 2004 | 9311 | 0.050 |
Why?
|
| Physician Assistants | 1 | 2003 | 193 | 0.050 |
Why?
|
| Fetal Macrosomia | 1 | 2001 | 124 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2003 | 739 | 0.050 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 11007 | 0.050 |
Why?
|
| Luteinizing Hormone | 1 | 2003 | 865 | 0.050 |
Why?
|
| Dandy-Walker Syndrome | 1 | 2000 | 43 | 0.050 |
Why?
|
| Confidence Intervals | 3 | 2001 | 2970 | 0.050 |
Why?
|
| Fetal Monitoring | 1 | 2000 | 70 | 0.050 |
Why?
|
| Polydactyly | 1 | 2000 | 57 | 0.050 |
Why?
|
| Labor Presentation | 1 | 2000 | 53 | 0.050 |
Why?
|
| Reference Values | 3 | 2010 | 4982 | 0.050 |
Why?
|
| Extraembryonic Membranes | 1 | 1999 | 41 | 0.040 |
Why?
|
| Oxytocin | 2 | 2001 | 394 | 0.040 |
Why?
|
| Predictive Value of Tests | 6 | 2013 | 15070 | 0.040 |
Why?
|
| Yolk Sac | 1 | 1999 | 75 | 0.040 |
Why?
|
| Toes | 1 | 2000 | 207 | 0.040 |
Why?
|
| Mass Screening | 1 | 2015 | 5252 | 0.040 |
Why?
|
| Cause of Death | 1 | 2010 | 3584 | 0.040 |
Why?
|
| Kidney Tubules | 1 | 2001 | 488 | 0.040 |
Why?
|
| Observer Variation | 3 | 2007 | 2593 | 0.040 |
Why?
|
| Critical Care | 1 | 2011 | 2644 | 0.040 |
Why?
|
| Labor, Obstetric | 1 | 2002 | 333 | 0.040 |
Why?
|
| Urine | 1 | 2000 | 370 | 0.040 |
Why?
|
| Congenital Abnormalities | 2 | 2000 | 707 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 1995 | 4586 | 0.040 |
Why?
|
| Biometry | 1 | 2001 | 558 | 0.040 |
Why?
|
| Fingers | 1 | 2000 | 514 | 0.040 |
Why?
|
| HELLP Syndrome | 1 | 1997 | 41 | 0.040 |
Why?
|
| Urinary Bladder | 2 | 2000 | 1172 | 0.040 |
Why?
|
| Reproducibility of Results | 4 | 2013 | 19907 | 0.040 |
Why?
|
| Endosonography | 1 | 2000 | 610 | 0.030 |
Why?
|
| Testicular Hydrocele | 1 | 1995 | 28 | 0.030 |
Why?
|
| Polyhydramnios | 1 | 1995 | 41 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2005 | 2246 | 0.030 |
Why?
|
| Spermatic Cord Torsion | 1 | 1995 | 73 | 0.030 |
Why?
|
| Vagina | 2 | 2016 | 825 | 0.030 |
Why?
|
| Cicatrix | 1 | 2021 | 764 | 0.030 |
Why?
|
| Gynecology | 1 | 2021 | 513 | 0.030 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 1996 | 140 | 0.030 |
Why?
|
| Facial Neoplasms | 1 | 1995 | 121 | 0.030 |
Why?
|
| Appendicitis | 1 | 2001 | 645 | 0.030 |
Why?
|
| Risk Assessment | 5 | 2013 | 23337 | 0.030 |
Why?
|
| Cervical Vertebrae | 1 | 2000 | 975 | 0.030 |
Why?
|
| Anthropometry | 1 | 1998 | 1350 | 0.030 |
Why?
|
| Reproductive Medicine | 1 | 2015 | 108 | 0.030 |
Why?
|
| Prognosis | 4 | 2014 | 29050 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2003 | 21752 | 0.030 |
Why?
|
| Rotation | 1 | 1995 | 523 | 0.030 |
Why?
|
| Abortion, Induced | 2 | 2014 | 458 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2018 | 35423 | 0.030 |
Why?
|
| Follow-Up Studies | 5 | 2013 | 39045 | 0.020 |
Why?
|
| Age Factors | 2 | 2010 | 18367 | 0.020 |
Why?
|
| Societies | 1 | 2011 | 104 | 0.020 |
Why?
|
| Prevalence | 2 | 2000 | 15226 | 0.020 |
Why?
|
| Gravidity | 1 | 2010 | 51 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2004 | 7784 | 0.020 |
Why?
|
| Abdomen | 1 | 2016 | 1118 | 0.020 |
Why?
|
| Regression Analysis | 1 | 1999 | 6461 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2016 | 20123 | 0.020 |
Why?
|
| Likelihood Functions | 2 | 2002 | 1005 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2005 | 8321 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2001 | 2237 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 1483 | 0.020 |
Why?
|
| Liver Diseases | 1 | 1996 | 1254 | 0.020 |
Why?
|
| Calcinosis | 1 | 1996 | 1499 | 0.020 |
Why?
|
| Massachusetts | 2 | 2013 | 8663 | 0.020 |
Why?
|
| Genetic Testing | 1 | 1998 | 3443 | 0.020 |
Why?
|
| Middle Aged | 8 | 2014 | 213367 | 0.020 |
Why?
|
| Neutrophils | 1 | 1997 | 3717 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 3086 | 0.010 |
Why?
|
| Organizational Case Studies | 1 | 2003 | 299 | 0.010 |
Why?
|
| Professional Autonomy | 1 | 2003 | 177 | 0.010 |
Why?
|
| Male | 7 | 2014 | 350027 | 0.010 |
Why?
|
| Incidence | 2 | 2013 | 20945 | 0.010 |
Why?
|
| Polyps | 1 | 2001 | 189 | 0.010 |
Why?
|
| Cesarean Section, Repeat | 1 | 1999 | 29 | 0.010 |
Why?
|
| Pregnancy Tests | 1 | 1999 | 30 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 9230 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 15538 | 0.010 |
Why?
|
| Risk | 1 | 2011 | 9685 | 0.010 |
Why?
|
| Adolescent | 3 | 2014 | 85759 | 0.010 |
Why?
|
| Pregnancy, Ectopic | 1 | 1999 | 141 | 0.010 |
Why?
|
| Diploidy | 1 | 1998 | 138 | 0.010 |
Why?
|
| Pediatrics | 1 | 2012 | 3469 | 0.010 |
Why?
|
| Dinoprostone | 1 | 1999 | 600 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2001 | 1849 | 0.010 |
Why?
|
| Probability | 1 | 2001 | 2505 | 0.010 |
Why?
|
| Time Factors | 3 | 2006 | 40063 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 1676 | 0.010 |
Why?
|
| Medical Records | 1 | 2001 | 1413 | 0.010 |
Why?
|
| ROC Curve | 1 | 2002 | 3527 | 0.010 |
Why?
|
| Leiomyoma | 1 | 2000 | 730 | 0.010 |
Why?
|
| Hysterectomy | 1 | 1999 | 927 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2003 | 2211 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1997 | 2030 | 0.010 |
Why?
|
| Linear Models | 1 | 2002 | 5953 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2008 | 40559 | 0.010 |
Why?
|
| Uterine Neoplasms | 1 | 2000 | 1513 | 0.010 |
Why?
|
| Infant | 1 | 2012 | 35129 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 10949 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 57768 | 0.000 |
Why?
|
| Heart Ventricles | 1 | 1998 | 3820 | 0.000 |
Why?
|
| Aged | 1 | 2013 | 163253 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2000 | 17449 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2000 | 40992 | 0.000 |
Why?
|
| Brain | 1 | 2000 | 26413 | 0.000 |
Why?
|
| Child | 1 | 2000 | 77679 | 0.000 |
Why?
|